Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion type Assertion NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_head.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion description "[Noncirrhotic HCV treatment-naive patients and prior relapsers received response-guided therapy (RGT) with peg-IFN/RBV for 24 or 48 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_provenance.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion evidence source_evidence_literature NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_provenance.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion SIO_000772 25192745 NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_provenance.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion wasDerivedFrom befree-2016 NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_provenance.
- NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_assertion wasGeneratedBy ECO_0000203 NP1217313.RAyDBt59N5r48mSjtSivoTOCa9OrHfHPB4TX65Pk-J63U130_provenance.